Effect of androgenic hormone combined with hydroxyurea (NSC-32065) on hematopoietic system of patients with cancer.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D006413:Hematopoietic System / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013739:Testosterone